Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide
Status:
Suspended
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine whether metabolic control centers in the brain can be
activated in patients with type 2 diabetes as compared to non-diabetic individuals. This is
important since people with diabetes have inappropriately high production of glucose, which
could be at least in part due to impaired activation of important brain centers.
Phase:
Phase 2
Details
Lead Sponsor:
Albert Einstein College of Medicine Albert Einstein College of Medicine, Inc.
Collaborators:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institutes of Health (NIH)